Association Between Hospital-Physician Vertical Integration and Medication Adherence Rates

Published in: Health Services Research (2022). doi: 10.1111/1475-6773.14090

Posted on RAND.org on October 28, 2022

by Jonathan S. Levin, Swad Komanduri, Christopher M. Whaley

Read More

Access further information on this document at Wiley Online Library

This article was published outside of RAND. The full text of the article can be found at the link above.

Objective

To test the association between vertical integration of primary care providers (PCPs) and adherence rates for anti-diabetics, renin angiotensin system antagonists (RASA), and statins.

Data Sources

Medicare Part B outpatient fee-for-service claims and Medicare Part D event data from 2014 to 2017.

Study Design

We estimated difference-in-differences regressions, comparing changes in adherence among patients with PCPs who converted from independent to integrated to changes among patients whose PCPs remained independent or integrated during the study period. To test for heterogeneous impacts by patient demographics, we estimated triple difference regressions that included additional interaction terms by comorbidity rates, age group, and race/ethnicity.

Extraction Methods

We extracted Medicare claims for adults with continuous enrollment in Parts B and D during the study period. Principal Findings

The proportion of patients who had a vertically integrated PCP increased by approximately 23% over the study period. Changes in adherence did not differ significantly between patients based on whether their PCP became integrated (Statins: 0.18, 95% CI –0.13, 0.49; RASA: –0.13, 95% CI –0.46, 0.19; Anti-Diabetics: –0.20, 95% CI –0.78, 0.38). Among patients with PCPs who became integrated, there were significant decreases in adherence for patients who were Black, Asian, Hispanic, or Native American, above 80 years old, and had greater comorbidities for all three classes.

Conclusions

While there were no average changes in adherence following vertical integration of PCPs, health equity worsened, with significant declines in adherence for Black, Asian, Hispanic, and Native American patients, patients over 80 years old, and patients with greater comorbidities. These findings suggest that integration may reduce clinician's incentives to compete based on quality of care delivered. Given the price increases associated with integration, integration may be a net welfare loss.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.